Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Water is the giver of life, but could it be a giver of untold medicines too?

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Walking through the mRNA manufacturing process – and its many challenges.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?